A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to see whether it is better to take delavirdine (DLV) plus indinavir (IDV) plus zidovudine (ZDV) twice a day or three times a day.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Patients are divided into 2 treatment groups; the groups are balanced with respect to viral load. Group A receives ZDV, DLV, and IDV 3 times daily. Group B receives ZDV, DLV, and IDV 2 times daily. Patients are evaluated for changes from baseline in viral load and CD4 cell count.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria
You may be eligible for this study if you:
-
Are HIV-positive.
-
Have a viral load (level of HIV in the blood) of at least 20,000 copies/ml.
-
Have a CD4 cell count of at least 50 cells/mm3.
-
Are at least 14 years old (consent of parent or guardian is required if under 18).
Exclusion Criteria
You will not be eligible for this study if you:
-
Have ever taken an anti-HIV drug other than ZDV.
-
Have taken ZDV for more than 1 month.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | AIDS Healthcare Foundation | Los Angeles | California | United States | 90027 |
2 | UCSF AIDS Research Institute | San Francisco | California | United States | 94105 |
3 | Saint Luke's - Roosevelt Hosp Ctr | New York | New York | United States | 10019 |
4 | Anderson Clinical Research | Pittsburgh | Pennsylvania | United States | 15213 |
5 | Univ of Tennessee / Div of Infect Dis / Dept of Med | Memphis | Tennessee | United States | 38165 |
6 | Infectious Disease Physicians Inc | Annandale | Virginia | United States | 22203 |
Sponsors and Collaborators
- Pharmacia and Upjohn
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 228G
- M/3331/0072